All Stories

  1. Glucocorticoid-Induced Hypocalcemia in a Patient with Established Hypoparathyroidism
  2. Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST)
  3. Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour
  4. Male Obesity Associated Gonadal Dysfunction and the Role of Bariatric Surgery
  5. Laparoscopic Adjustable Gastric Banding—Should a Second Chance Be Given?
  6. Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study
  7. Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant
  8. Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice
  9. Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection
  10. Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms
  11. Identification of an optimal threshold for detecting human brown adipose tissue using receiver operating characteristic analysis of IDEAL MRI fat fraction maps
  12. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
  13. Effects of visfatin on brown adipose tissue energy regulation using T37i cells
  14. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome
  15. Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations
  16. Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion
  17. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy
  18. Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
  19. Potential Hormone Mechanisms of Bariatric Surgery
  20. Brown fat depots in adult humans remain static in their locations on PET/CT despite changes in seasonality
  21. Hypertestosteronemia and Infertility from a Mediastinal Extragonadal Germ Cell Tumor
  22. Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies
  23. Microvascular complications after metabolic surgery
  24. Paraneoplastic endocrine syndromes
  25. Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines
  26. PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude
  27. Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation
  28. Obesity-related metabolic and reproductive dysfunction: variations between the sexes
  29. Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours
  30. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
  31. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study
  32. Short-Chain Fatty Acid Acetate Stimulates Adipogenesis and Mitochondrial Biogenesis via GPR43 in Brown Adipocytes
  33. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
  34. Severe paraneoplastic hypoglycemia secondary to a gastrointestinal stromal tumour masquerading as a stroke
  35. Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell t...